[Algimaf treatment of trophic ulcers].
A new biologically active preparation, algimaf, developed at the All-Union Research Institute for Medical Polymers, stimulates the regenerative processes, is characterized by analgesic, antiedematous, manifest antibacterial and hemostatic effects, promotes the formation of hardly visible cicatrices, and is a highly effective means for the management of trophic ulcers of the skin.
Sogomonian
L M
LM
Iakubovich
V S
VS
D000328:Adult; D000368:Aged; D000464:Alginates / Q000009:adverse effects / Q000627:therapeutic use*; D001458:Bandages / Q000009:adverse effects; D001684:Biological Dressings / Q000009:adverse effects; D002675:Child, Preschool; D002908:Chronic Disease; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008272:Mafenide / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012883:Skin Ulcer / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects
D000464:Alginates; D004338:Drug Combinations; D013449:Sulfonamides; D008272:Mafenide
Lechenie troficheskikh iazv al'gimafom.